2022    2021    2020    2019    2018    2017    2016    2015    2014   


   
   


   

Check our Open Access Repository.

2022


18 publication(s):

Note: when necessary, only the first 15 authors are displayed.

International refereed journal articles

1 - 
Ibrutinib Associated with Rituximab-Platinum Salt-Based Immunochemotherapy in B-Cell Lymphomas: Results of a Phase 1b-II Study of the LYSA Group
C. Bonnet, J. Dupuis, H. Tilly, T. Lamy, C. Fruchart, S. Le Gouill, C. Thieblemont, F. Morschhauser, O. Casasnovas, K. Bouabdallah, H. Ghesquieres, E. van den Neste, M. Andre, G. Cartron, G. Salles et al.
Cancers, MDPI, 2022, 14 (7), pp.1761.
DOI : https://doi.org/10.3390/cancers14071761
Pubmed : 35406532
PDF file
 Reprint request: Subject to availability
2 - 
From B-cell self-control to therapeutic approaches, could B-cell intrinsic strategies temper IgE responses and IgE memory?
M. Cogné, Z. Dalloul, O. Dézé, M. Le Goff, S. Thomas, M. Cahen, N. Ueda, B. Laffleur
Du self-control lymphocytaire B aux abords thérapeutiques, quelles voies « B-intrinsèques » pour tempérer les réponses et la mémoire IgE ?. Revue francaise d'allergologie, Elsevier, 2022,
DOI : https://doi.org/10.1016/j.reval.2021.10.012
PDF file
 Reprint request: Subject to availability
3 - 
Bendamustine-EAM versus R-BEAM after high-dose cytarabine-based induction in newly diagnosed patients with mantle cell lymphoma, a LYSA retrospective study
D. Costes-Tertrais, T. Hueso, T. Gastinne, C. Thieblemont, L. Oberic, K. Bouabdallah, S. Garciaz, E. Tchernonog, C. Dartigeas, V. Ribrag, P. Fogarty, R.-O. Casasnovas, R. Houot, C. Delette, S. Malak et al.
Bone Marrow Transplantation, Nature Publishing Group, 2022,
DOI : https://doi.org/10.1038/s41409-022-01596-8
Pubmed : 35149851
 Reprint request: Subject to availability
4 - 
Toward a Better Classification System for NK-LGL Disorders
G. Drillet, C. Pastoret, A. Moignet, T. Lamy, T. Marchand
Frontiers in Oncology, Frontiers, 2022, 12, pp.821382.
DOI : https://doi.org/10.3389/fonc.2022.821382
Pubmed : 35178350
PDF file
 Reprint request: Subject to availability
5 - 
Safety and preliminary efficacy of allogeneic bone marrow-derived multipotent mesenchymal stromal cells for systemic sclerosis: a single-centre, open-label, dose-escalation, proof-of-concept, phase 1/2 study
D. Farge, S. Loisel, M. Resche-Rigon, P. Lansiaux, I. Colmegna, D. Langlais, C. Charles, G. Pugnet, A. T. J. Maria, E. Chatelus, T. Martin, E. Hachulla, V. D. Kheav, N. C. Lambert, H. C. Wang et al.
The Lancet Rheumatology, Elsevier, 2022, 4 (2), pp.E91-E104.
DOI : https://doi.org/10.1016/S2665-9913(21)00326-X
PDF file
 Reprint request: Subject to availability
6 - 
Molecular networking for drug toxicities studies: The case of hydroxychloroquine in covid-19 patients
P.-J. Ferron, B. Le Daré, J. Bronsard, C. Steichen, E. Babina, R. Pelletier, T. Hauet, I. Morel, K. Tarte, F. Reizine, B. Clément, B. Fromenty, T. Gicquel
International Journal of Molecular Sciences, MDPI, 2022, 23 (1), pp.82.
DOI : https://doi.org/10.3390/ijms23010082
Pubmed : 35008505
PDF file
 Reprint request: Subject to availability
7 - 
Pivotal role of PIM2 kinase in plasmablast generation and plasma cell survival, opening new treatment options in myeloma
M. Haas, G. Caron, F. Chatonnet, S. Manenti, E. Alaterre, J. Devin, C. Delaloy, G. Bertolin, R. Viel, A. Pignarre, F. Llamas Gutierrez, A. Marchalot, O. Decaux, K. Tarte, L. Delpy et al.
Blood, American Society of Hematology, 2022,
DOI : https://doi.org/10.1182/blood.2021014011
Pubmed : 35108359
PDF file
 Reprint request: Subject to availability
8 - 
Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma
R. Houot, V. Poeschel, B. Altmann, S. Angel, L. Thurner, T. Illmer, M. Andre, M. Dreyling, H. Maisonneuve, H. Tilly, S. Mayer, O. Casasnovas, S. Le Gouill, F. Offner, G. Cartron et al.
Hemasphere, 2022, 6 (2),
DOI : https://doi.org/10.1097/HS9.0000000000000672
Pubmed : 35028526
PDF file
 Reprint request: Subject to availability
9 - 
RNA-based immunoglobulin repertoire sequencing is a new tool for the management of monoclonal gammopathy of renal (kidney) significance
V. Javaugue, V. Pascal, S. Bender, S. Nasraddine, M. Dargelos, M. Alizadeh, A. Saintamand, M. Filloux, P. Derouault, S. Bouyer, E. Desport, A. Jaccard, F. Bridoux, M. Cogné, C. Sirac et al.
Kidney International, Nature Publishing Group, 2022, 101 (2), pp.331-337.
DOI : https://doi.org/10.1016/j.kint.2021.10.017
Pubmed : 34767830
PDF file
 Reprint request: Subject to availability
10 - 
Disease-specific outcomes after chimeric antigen receptor T-cell therapy
J. Lemoine, S. Vic, R. Houot
European Journal of Cancer, Elsevier, 2022, 160, pp.235-242.
DOI : https://doi.org/10.1016/j.ejca.2021.10.022
Pubmed : 34865943
 Reprint request: Subject to availability


Export data displayed in CSV Export data displayed in RTF